SPP1 and melanoma: Studies show that melanoma inhibitory activity (MIA), osteopontin (OPN) and tissue polypeptide-specific antigen cytokeratin 18 (TSP) are significantly elevated in serum of metastatic UM patients when compared with nonmetastatic patients (Table 5).